Jeanmarie Guenot, Ph.D. has over 20 years as a business executive with her expertise in the scientific biotechnology and pharmaceutical industry. Her talents and interests are in establishing companies in these fields with ophthalmology being her primary interest. Ms. Guenot has spent her career in preparing and building all stages of several businesses, and some of these include corporate and commercial development and venture capital at https://www.linkedin.com/in/jeanmarie-guenot-4a140617.
The resume of Ms. Guenot is extensive; her most recent achievement is founding and managing SKS Ocular and SKS Ocular 1. They are start-up companies in orthology with an ophthalmic incubator. She accumulated a portfolio of five companies, which focuses on a sustained release ocular drug, inflammation of the eye and glaucoma therapies with varied delivery techniques. She has concentrated work on macular degeneration.
Dr. Jeanmarie Guenot was a business advisor for Hoffmann-La Roche in Basel and Shanghai in 2008-2009. She led the licensing division in Corporate & Business Development at PDL BioPharma. As a female Ph.D., she has a thorough education. She graduated with her MBA from The Wharton School at the University of Pennsylvania. Her major was in medical and physical chemistry; she attended the University of California and received her Ph.D.
After leaving the Universities, her education took her to a business career at Atlas Venture. where she gained expertise in managing venture capital investments noted on amphivena.com. In her next position, she was the main scientist in preclinical R&D at Hoffmann-La Roche. She developed drugs and trained other scientists.
Dr. Guenot is a professional scientist and venture capitalist that has a prestigious position and continues to grow in both fields.